Antonio Gasbarrini to Recurrence
This is a "connection" page, showing publications Antonio Gasbarrini has written about Recurrence.
Connection Strength
0.132
-
Maintaining standard volumes, efficacy and safety, of fecal microbiota transplantation for C. difficile infection during the COVID-19 pandemic: A prospective cohort study. Dig Liver Dis. 2020 12; 52(12):1390-1395.
Score: 0.026
-
Madelung's disease and acute alcoholic hepatitis: case report and review of literature. Eur Rev Med Pharmacol Sci. 2019 Jul; 23(14):6272-6276.
Score: 0.024
-
Fecal calprotectin in management of Clostridium difficile infection: a longitudinal study. Scand J Gastroenterol. 2018 05; 53(5):567-572.
Score: 0.021
-
Recommendations for the inclusion of Fabry disease as a rare febrile condition in existing algorithms for fever of unknown origin. Intern Emerg Med. 2017 Oct; 12(7):1059-1067.
Score: 0.021
-
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year cohort study: authors' reply. Clin Microbiol Infect. 2017 11; 23(11):891.
Score: 0.020
-
Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study. Clin Microbiol Infect. 2017 May; 23(5):337.e1-337.e3.
Score: 0.020